<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02826083</url>
  </required_header>
  <id_info>
    <org_study_id>VERGES FUI 2014</org_study_id>
    <nct_id>NCT02826083</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Effects of XXS on Oxidative Stress in Patients With Mild or Moderate Hyperlipidemia</brief_title>
  <acronym>XXS SYMPA</acronym>
  <official_title>Randomized, Double-blind Study to Evaluate the Effects of XXS on Oxidative Stress in Patients With Mild or Moderate Hyperlipidemia and on Lipoprotein Kinetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      Given preliminary data in animal (proprietary data) have shown that XXS (a mixture of natural
      polyphenolic extracts of edible plants) has a significant and favourable effect on oxidative
      stress notably with a decrease in certain markers of oxidative stress and on plasma lipid
      parameters, the investigator proposes to study the effect of 6 months of treatment with XXS
      in a controlled study against placebo in a population of persons presenting a lipid profile
      at the upper limit of normal.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification of Malondialdehyde (MDA)</measure>
    <time_frame>Change from baseline at 1 month, 3 months, 6 months after treatment with XXS</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantification of oxidized Low Density Lipoprotein (LDL)</measure>
    <time_frame>Change from baseline at 1 month, 3 months, 6 months after treatment with XXS</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure of overall free-radical defences in the blood by KRL Kyrial Internationaltest</measure>
    <time_frame>Change from baseline at 1 month, 3 months, 6 months after treatment with XXS</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Quantification of LDL</measure>
    <time_frame>Change from baseline at 1 month, 3 months, 6 months after treatment with XXS</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Quantification of High Density Lipoprotein (HDL)</measure>
    <time_frame>Change from baseline at 1 month, 3 months, 6 months after treatment with XXS</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>XXS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>XXS</intervention_name>
    <arm_group_label>XXS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>non-XXS</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Persons who have provided written consent

          -  Persons aged over 18 years

          -  Presenting LDL levels between 1.30 and 1.90 g/l and/or triglyceride levels between 1.5
             and 3 g/l

        Exclusion Criteria:

          -  Persons without national health insurance cover

          -  Pregnant or breastfeeding women

          -  Adults under guardianship

          -  Patients with diabetes (Insulin-Dependent Diabetes (IDD) or Non-Insulin-Dependent
             Diabetes NIDD)

          -  Patients with coronary artery disease

          -  Patients with atherosclerosis

          -  HDL&gt;0.80 g/l

          -  receiving treatment with lipid-lowering agents (statins, fibrates, ezetimibe or Ω3)

          -  Consuming vitamin supplements (A, C, E…)

          -  Consuming oligoelements or minerals (Se, Zn, Ca…)

          -  Renal insufficiency (creatinine clearance &lt; 30 ml/min calculated according to the
             Modification of the Diet in Renal Disease (MDRD))
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bruno VERGES</last_name>
    <phone>03.80.29.34.53</phone>
    <phone_ext>33</phone_ext>
    <email>bruno.verges@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno VERGES</last_name>
      <phone>03 80 29 34 53</phone>
      <phone_ext>33</phone_ext>
      <email>bruno.verges@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2016</study_first_submitted>
  <study_first_submitted_qc>July 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 7, 2016</study_first_posted>
  <last_update_submitted>July 4, 2016</last_update_submitted>
  <last_update_submitted_qc>July 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

